本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tevogen Bio Holdings

1.01
+0.03163.23%
盘后0.9920-0.0180-1.78%19:59 EDT
成交量:77.23万
成交额:77.82万
市值:1.86亿
市盈率:-14.42
高:1.03
开:0.9895
低:0.9700
收:0.9784
数据加载中...
2025/05/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/25

重要事件披露

Form 8-K - Current report
2025/04/18

重要事件披露

Form 8-K - Current report
2025/04/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

重要事件披露

Form 8-K - Current report
2024/11/19

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/08/23

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/01

SEC问询函

Form CORRESP - Correspondence
2024/07/31

SEC问询函

Form CORRESP - Correspondence
2024/07/29

SEC问询函

Form CORRESP - Correspondence
2024/07/23

SEC问询函

Form CORRESP - Correspondence
2024/07/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/22

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/22

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report